Abstract
Introduction: Over the years, the importance of periodontal medicine has grown as associations between Periodontal Disease (PD) and other non-infectious systemic diseases have been discovered and among these interactions we can mention Cardiovascular Diseases (CVDs). Objectives: To update dentists and periodontists on the bidirectional relationship between PD and atherosclerosis. Materials and Methods: The definition of the research question was: “Does periodontal disease have a systemic influence on cardiovascular disease atherosclerosis?”. Then, searches were performed on the platforms PubMed, SciELO, MEDLINE, LILACS, using the descriptors "periodontal disease" AND "atherosclerosis" AND "cardiovascular disease". The inclusion criteria were articles published between 2010 and 2021, in Portuguese and English, which were available in full for reading, presenting considerations on the relationship of atherosclerosis with PD, being case-control studies, systematic review with or without meta-analysis, literature review, randomized clinical trials and case series. Discussion: Among the mechanisms proposed for this relationship, it is suggested that systemic inflammation seems to play an important role in periodontal pathogenesis, this systemic pro-inflammatory state arising from the presence of atherosclerotic plaques can trigger will result in a more aggressive reaction of the immune system causing a irreversible damage to the vascular lumen, allowing the migration of periodontal pathogens to the circulation. Conclusion: We conclude that PD can generate some interaction with cardiovascular diseases. Through this literature review we verified that periodontal pathogens will bind to atherosclerotic plaques causing an increase in the local and systemic pro-inflammatory state, resulting in more severe conditions.
References
Li C, Lv Z, Shi Z, Zhu Y, Wu Y, Li L, et al. Periodontal therapy for the management of cardiovascular disease in patients with chronic periodontitis. Cochrane Database Syst Rev. 2017, 7; 11(11): CD009197.
Aoyama N, Kobayashi N, Hanatani T, Ashigaki N, Yoshida A, Shiheido Y, et al. Periodontal condition in Japanese coronary heart disease patients: A comparison between coronary and non-coronary heart diseases. J Periodontal Res. 2019, 54(3): 259-265.
Aarabi G, Zeller T, Seedorf H, Reissmann DR, Heydecke G, Schaefer AS, et al. Genetic Susceptibility Contributing to Periodontal and Cardiovascular Disease. J Dent Res. 2017, 96(6): 610-617.
Monsarrat P, Blaizot A, Kémoun P, Ravaud P, Nabet C, Sixou M, et al. Clinical research activity in periodontal medicine: a systematic mapping of trial registers. J Clin Periodontol. 2016, 43(5):390–400.
Loos BG. Periodontal medicine: work in progress! J Clin Periodontol. 2016, 43(6):470-1.
Caffesse RG, Echeverría JJ. Treatment trends in periodontics. Periodontol 2000. 2019, 79(1):7-14.
Caúla AL, Lira-Junior R, Tinoco EM, Fischer RG. The effect of periodontal therapy on cardiovascular risk markers: a 6-month randomized clinical trial. J Clin Periodontol. 2014, 41(9): 875-82.
Yu YH, Chasman DI, Buring JE, Rose L, Ridker PM. Cardiovascular risks associated with incident and prevalent periodontal disease. J Clin Periodontol. 2015, 42(1): 21-8.
Carrizales-Sepúlveda EF, Ordaz-Farías A, Vera-Pineda R, Flores-Ramírez R. Periodontal Disease, Systemic Inflammation and the Risk of Cardiovascular Disease. Heart Lung Circ. 2018, 27(11): 1327-1334.
Goulart AC, Armani F, Arap AM, Nejm T, Andrade JB, Bufarah HB, et al. Relationship between periodontal disease and cardiovascular risk factors among young and middle-aged Brazilians. Cross-sectional study. Sao Paulo Med J. 2017, 135(3): 226-233.
Ying Ouyang X, Mei Xiao W, Chu Y, Ying Zhou S. Influence of periodontal intervention therapy on risk of cardiovascular disease. Periodontol 2000. 2011, 56(1): 227-57.
Cullinan MP, Palmer JE, Faddy MJ, Westerman B, Carle AD, West MJ, et al. The Influence of Triclosan on Biomarkers of Cardiovascular Risk in Patients in the Cardiovascular and Periodontal Study (CAPS): A Randomized Controlled Trial. J Periodontol. 2015, 86(7): 847-55.
Bui FQ, Almeida-da-Silva CL, Huynh B, Trinh A, Liu J, Woodward J, et al. Association between periodontal pathogens and systemic disease. Biomed J. 2019, 42 (1): 27-35.
Loos BG, Van Dyke TE. The role of inflammation and genetics in periodontal disease. Periodontol 2000. 2020, 83(1): 26-39.
Curtis MA, Diaz PI, Van Dyke TE. The role of the microbiota in periodontal disease. Periodontol 2000. 2020, 83(1):14-25.
Orlandi M, Graziani F, D'Aiuto F. Periodontal therapy and cardiovascular risk. Periodontol 2000. 2020, 83(1): 107-124.
Ying Ouyang X, Mei Xiao W, Chu Y, Ying Zhou S. Influence of periodontal intervention therapy on risk of cardiovascular disease. Periodontol 2000. 2011, 56 (1): 227-57.
Herrera D, Molina A, Buhlin K, Klinge B. Periodontal diseases and association with atherosclerotic disease. Periodontol 2000. 2020, 83(1): 66-89.
Liu W, Cao Y, Dong L, Zhu Y, Wu Y, Lv Z, et al. Periodontal therapy for primary or secondary prevention of cardiovascular disease in people with periodontitis. Cochrane Database Syst Rev. 2019, 31; 12(12): CD009197.
Abusleme L, Dupuy AK, Dutzan N, Silva N, Burleson JA, Strausbaugh LD, et al. The subgingival microbiome in health and periodontitis and its relationship with community biomass and inflammation. ISME J. 2013, 7(5):1016-25.
Hong BY, Furtado Araujo MV, Strausbaugh LD, Terzi E, Ioannidou E, Diaz PI. Microbiome profiles in periodontitis in relation to host and disease characteristics. PLoS One. 2015, 18; 10(5):e0127077.
Schincaglia GP, Hong BY, Rosania A, Barasz J, Thompson A, Sobue T, et al. Clinical, Immune, and Microbiome Traits of Gingivitis and Peri-implant Mucositis. J Dent Res. 2017, 96(1):47-55.
Beck JD, Papapanou PN, Philips KH, Offenbacher S. Periodontal Medicine: 100 Years of Progress. J Dent Res. 2019, 98(10):1053-1062.
Monsarrat P, Blaizot A, Kémoun P, Ravaud P, Nabet C, Sixou M, et al. Clinical research activity in periodontal medicine: a systematic mapping of trial registers. J Clin Periodontol. 2016, 43(5):390–400.
Loos BG. Periodontal medicine: work in progress! J Clin Periodontol. 2016, 43(6):470-1.
Caffesse RG, Echeverría JJ. Treatment trends in periodontics. Periodontol 2000. 2019, 79(1):7-14.
Vettore MV, Marques RA, Peres MA. Social inequalities and periodontal disease: multilevel approach in SBBrasil 2010 survey. Rev Saude Publica. 2013, 47 Suppl 3:29-39.
Takeuchi H, Furuta N, Morisaki I, Amano A. Exit of intracellular Porphyromonas gingivalis from gingival epithelial cells is mediated by endocytic recycling pathway. Cell Microbiol. 2011, 13(5):677-91.
Carrion J, Scisci E, Miles B, Sabino GJ, Zeituni AE, Gu Y, et al. Microbial carriage state of peripheral blood dendritic cells (DCs) in chronic periodontitis influences DC differentiation, atherogenic potential. J Immunol. 2012, 15; 189(6):3178-87.
Priyamvara A, Dey AK, Bandyopadhyay D, Katikineni V, Zaghlol R, Basyal B, et al. Periodontal Inflammation and the Risk of Cardiovascular Disease. Curr Atheroscler Rep. 2020, 8;22(7):28.

This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2021 Isabelle de Souza Silva, Gisele Cardias Pereira Alves, Adevaldo Siriano Barbosa Junior, Adriana Gutierrez Payao, Carlos Eduardo Vieira da Silva Gomes, Max Pinto da Costa da Rocha, Ana Cláudia Braga Amoras Alves, Ricardo Fonseca